[go: up one dir, main page]

BR9610239A - Xcd32-allergen-fusion proteins - Google Patents

Xcd32-allergen-fusion proteins

Info

Publication number
BR9610239A
BR9610239A BR9610239A BR9610239A BR9610239A BR 9610239 A BR9610239 A BR 9610239A BR 9610239 A BR9610239 A BR 9610239A BR 9610239 A BR9610239 A BR 9610239A BR 9610239 A BR9610239 A BR 9610239A
Authority
BR
Brazil
Prior art keywords
xcd32
allergen
fusion proteins
fusion
proteins
Prior art date
Application number
BR9610239A
Other languages
Portuguese (pt)
Inventor
Geert C Mudde
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9610239A publication Critical patent/BR9610239A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
    • C07K14/43513—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae
    • C07K14/43531—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from arachnidae from mites
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/35—Allergens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against Fc-receptors, e.g. CD16, CD32, CD64
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Insects & Arthropods (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pulmonology (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
BR9610239A 1995-08-16 1996-08-16 Xcd32-allergen-fusion proteins BR9610239A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9516760.7A GB9516760D0 (en) 1995-08-16 1995-08-16 Organic compounds
PCT/EP1996/003616 WO1997007218A1 (en) 1995-08-16 1996-08-16 Allergen-xcd32 fusion proteins

Publications (1)

Publication Number Publication Date
BR9610239A true BR9610239A (en) 1999-06-15

Family

ID=10779307

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9610239A BR9610239A (en) 1995-08-16 1996-08-16 Xcd32-allergen-fusion proteins

Country Status (16)

Country Link
EP (1) EP0846178A1 (en)
JP (1) JPH11513025A (en)
KR (1) KR19990036440A (en)
CN (1) CN1193353A (en)
AU (1) AU6873596A (en)
BR (1) BR9610239A (en)
CA (1) CA2227795A1 (en)
CZ (1) CZ43798A3 (en)
GB (1) GB9516760D0 (en)
HU (1) HUP9802349A3 (en)
IL (1) IL122898A0 (en)
NO (1) NO980566D0 (en)
PL (1) PL324897A1 (en)
SK (1) SK19398A3 (en)
TR (1) TR199800214T1 (en)
WO (1) WO1997007218A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9724531D0 (en) 1997-11-19 1998-01-21 Smithkline Biolog Novel compounds
CA2311574A1 (en) 1997-12-02 1999-06-10 Medarex, Inc. Cells expressing anti-fc receptor binding components
EP1221317A1 (en) * 2000-12-28 2002-07-10 SHAN-Beteiligungsgesellschaft m.b.H. Vaccines containing hybrid polypeptides consisting of at least two different allergenic proteins
US8025873B2 (en) 2002-06-20 2011-09-27 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8029803B2 (en) 2002-06-20 2011-10-04 Paladin Labs, Inc. Chimeric antigens for eliciting an immune response
US8007805B2 (en) 2003-08-08 2011-08-30 Paladin Labs, Inc. Chimeric antigens for breaking host tolerance to foreign antigens
BG65715B1 (en) * 2003-09-04 2009-08-31 Чавдар ВАСИЛЕВ Device for selective suppression of pathologic dna-specific b cells
BG65954B1 (en) * 2005-01-05 2010-07-30 Чавдар ВАСИЛЕВ Means for selective suppression of the activity of pathologic autoreactive b-cells
US9636415B2 (en) 2006-03-03 2017-05-02 S-Target Therapeutics Gmbh Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
EP1829895A1 (en) * 2006-03-03 2007-09-05 f-star Biotechnologische Forschungs- und Entwicklungsges.m.b.H. Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies
PL2861240T3 (en) 2012-06-15 2021-07-05 Immunomic Therapeutics, Inc. NUCLEIC ACIDS FOR THE TREATMENT OF ALLERGIES
JP6466327B2 (en) 2012-07-13 2019-02-06 エス−ターゲット・セラピューティクス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツングＳ−ＴＡＲｇｅｔ ｔｈｅｒａｐｅｕｔｉｃｓ ＧｍＢＨ Immunomodulating vaccine
EP2914285B1 (en) * 2012-11-01 2016-11-30 Veterinærinstituttet New fusion proteins for the treatment of allergic diseases
US9005630B2 (en) 2012-11-01 2015-04-14 Veterinaerinstituttet Fusion proteins for the treatment of allergic diseases
HUE037252T2 (en) 2013-05-21 2018-08-28 Tyg Oncology Ltd Gastrin peptide immunogenic composition
CN113186167B (en) * 2021-04-28 2021-11-30 中国食品药品检定研究院 Method for determining biological activity of anti-CD 20 monoclonal antibody drug ADCP

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994024281A1 (en) * 1993-04-14 1994-10-27 Immulogic Pharmaceutical Corporation T cell epitopes of the major allergens from dermatophagoides (house dust mite)
WO1995032734A1 (en) * 1994-05-26 1995-12-07 Innogenetics N.V. New methods and compounds for the selective modulation of antigen-specific t-cell responsiveness

Also Published As

Publication number Publication date
AU6873596A (en) 1997-03-12
CN1193353A (en) 1998-09-16
IL122898A0 (en) 1998-08-16
NO980566L (en) 1998-02-10
HUP9802349A3 (en) 1999-04-28
MX9801253A (en) 1998-05-31
PL324897A1 (en) 1998-06-22
WO1997007218A1 (en) 1997-02-27
EP0846178A1 (en) 1998-06-10
TR199800214T1 (en) 1998-06-22
NO980566D0 (en) 1998-02-10
KR19990036440A (en) 1999-05-25
JPH11513025A (en) 1999-11-09
CA2227795A1 (en) 1997-02-27
HUP9802349A2 (en) 1999-01-28
GB9516760D0 (en) 1995-10-18
SK19398A3 (en) 1998-09-09
CZ43798A3 (en) 1998-06-17

Similar Documents

Publication Publication Date Title
BR9609682A (en) Low-nuanced photo-disinfectants
DK0825860T3 (en) Prepare
BR9610239A (en) Xcd32-allergen-fusion proteins
BR9609671A (en) Amino uracilas substituted
BR9606951A (en) Killing proteins
BR9606756A (en) Peptide
NO981052D0 (en) peptide
PT839024E (en) FORMULACOES DE MONENSINA
NO981051D0 (en) peptide
BR9501643A (en) Helistato
FI955917A0 (en) Plattkontaktskena
BR7500505U (en) Knife-grinder
SE9504467D0 (en) Peptide
BR1100812A (en) Peptide
KR960028533U (en) ＂T＂
FI1871U1 (en) Kopplingsstycke Foer en motorsaog
BR9500079A (en) Bomballoon
BR7501426U (en) Búlica
BR9502123A (en) Tramplifier
BR9501962A (en) Lotofone
BR9501801A (en) Taxialerta
BR9502823A (en) Proteserra
BR9500744A (en) Tapafugeo
BR9502885A (en) Casarreal
BR9500075A (en) Carrapetilha

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law